191 related articles for article (PubMed ID: 33493092)
1. Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung-Function Decline.
Vera L; Garcia-Olloqui P; Petri E; Viñado AC; Valera PS; Blasco-Iturri Z; Calvo IA; Cenzano I; Ruppert C; Zulueta JJ; Prosper F; Saez B; Pardo-Saganta A
Am J Respir Cell Mol Biol; 2021 Apr; 64(4):465-476. PubMed ID: 33493092
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
3. Role of IGF-1 pathway in lung fibroblast activation.
Hung CF; Rohani MG; Lee SS; Chen P; Schnapp LM
Respir Res; 2013 Oct; 14(1):102. PubMed ID: 24103846
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis.
Hu B; Wu Z; Bai D; Liu T; Ullenbruch MR; Phan SH
Am J Pathol; 2015 Nov; 185(11):3066-75. PubMed ID: 26358219
[TBL] [Abstract][Full Text] [Related]
5. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.
Hofmann K; Fiedler S; Vierkotten S; Weber J; Klee S; Jia J; Zwickenpflug W; Flockerzi V; Storch U; Yildirim AÖ; Gudermann T; Königshoff M; Dietrich A
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):560-568. PubMed ID: 27932059
[TBL] [Abstract][Full Text] [Related]
6. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.
Borensztajn K; Bresser P; van der Loos C; Bot I; van den Blink B; den Bakker MA; Daalhuisen J; Groot AP; Peppelenbosch MP; von der Thüsen JH; Spek CA
Am J Pathol; 2010 Dec; 177(6):2753-64. PubMed ID: 20971733
[TBL] [Abstract][Full Text] [Related]
9. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
10. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
11. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil extracellular traps promote differentiation and function of fibroblasts.
Chrysanthopoulou A; Mitroulis I; Apostolidou E; Arelaki S; Mikroulis D; Konstantinidis T; Sivridis E; Koffa M; Giatromanolaki A; Boumpas DT; Ritis K; Kambas K
J Pathol; 2014 Jul; 233(3):294-307. PubMed ID: 24740698
[TBL] [Abstract][Full Text] [Related]
13. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
14. Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis.
Chen H; Qu J; Huang X; Kurundkar A; Zhu L; Yang N; Venado A; Ding Q; Liu G; Antony VB; Thannickal VJ; Zhou Y
Nat Commun; 2016 Aug; 7():12564. PubMed ID: 27535718
[TBL] [Abstract][Full Text] [Related]
15. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.
Dong J; Ma Q
Part Fibre Toxicol; 2017 Jun; 14(1):18. PubMed ID: 28595626
[TBL] [Abstract][Full Text] [Related]
17. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
[TBL] [Abstract][Full Text] [Related]
19. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
